Positively Aware

Positively Aware Positively Aware is the country's most widely read HIV treatment education journal. Visit us at: http

Brian Minalga, MSW, talks with two researchers, Sanjay R. Mehta, MD, and Susan Little, MD, who have developed a new appr...
11/18/2025

Brian Minalga, MSW, talks with two researchers, Sanjay R. Mehta, MD, and Susan Little, MD, who have developed a new approach to molecular HIV surveillance that could address stigma and privacy-related concerns.
positivelyaware.com/hiv-surveillance-data

Mark S. King is turning 65 so he’s having a virtual birthday celebrating people with / AIDS and turning it into a fund...
11/13/2025

Mark S. King is turning 65 so he’s having a virtual birthday celebrating people with / AIDS and turning it into a fundraiser for The Reunion Project, the nationwide network of long-term survivors.
positivelyaware.com/mark-king-birthday-party

With record sales of its HIV drug Biktarvy and longtime oral PrEP drug Descovy and the debut of Yeztugo, its six-month l...
11/10/2025

With record sales of its HIV drug Biktarvy and longtime oral PrEP drug Descovy and the debut of Yeztugo, its six-month long-acting injectable for PrEP, Gilead Sciences reported $7.3 billion in third-quarter sales—$5.3 billion of which came from its HIV business. Also, Biktarvy gets an extended lease on life.
positivelyaware.com/gilead-3q-sales

Funded by ViiV Healthcare, maker of cabotegravir, the ongoing study will look at injection site reactions over a six-mon...
11/08/2025

Funded by ViiV Healthcare, maker of cabotegravir, the ongoing study will look at injection site reactions over a six-month post-injection period to measure participants’ willingness to use either cabotegravir or lenacapavir, produced by Gilead Sciences.
positivelyaware.com/clarity-study-results

Eleven years ago the hepatitis C drug sofosbuvir was launched by Gilead at $82,000 per person for a 12-week regimen. “Th...
11/08/2025

Eleven years ago the hepatitis C drug sofosbuvir was launched by Gilead at $82,000 per person for a 12-week regimen. “That year we predicted that it could be made for between $68 and $136 and now you can buy sofosbuvir as a generic for $21,” says the researcher whose team who now says $25 for lenacapvir, the six-month injectable for PrEP, is possible.
positivelyaware.com/25-dollar-lenacapavir

Does medical mistrust hurt Latinos when accessing HIV prevention? The Chicago Q***r Latine Collaborative and Northwester...
11/06/2025

Does medical mistrust hurt Latinos when accessing HIV prevention? The Chicago Q***r Latine Collaborative and Northwestern University’s Feinberg School of Medicine want to interview healthcare and social service providers of Latino gay, bi and q***r men in Cook County to study how to overcome barriers to prevention. Compensation will be provided.

Contact: directors@cqlab.info

For the second time in a row, health secretary Robert F. Kennedy, Jr., has postponed a meeting of the medical expert pan...
11/01/2025

For the second time in a row, health secretary Robert F. Kennedy, Jr., has postponed a meeting of the medical expert panel that decides which preventive health services—such as PrEP—must be covered by insurers at no cost to patients. An HHS spokesperson cited the federal government shutdown as the cause and blamed Democrats.

positivelyaware.com/USPSTF-meeting-canceled-again

“I’ve learned to thrive with and because of my diagnosis,” writes Bridgette Picou. “Yet, I find myself back full circle....
10/26/2025

“I’ve learned to thrive with and because of my diagnosis,” writes Bridgette Picou. “Yet, I find myself back full circle. Worrying about dying and HIV. Or rather, once again worrying about how not to die while navigating life with HIV.”

Read her op-ed piece here:
https://positivelyaware.com/living-by-not-dying

More than 500 PrEP users and prevention advocates signed on to a letter sent to the CEOs of CVS Health and drugmaker G...
10/15/2025

More than 500 PrEP users and prevention advocates signed on to a letter sent to the CEOs of CVS Health and drugmaker Gilead Sciences, urging their two companies to work together to allow Gilead’s twice-yearly PrEP drug, , onto the pharmacy benefits manager’s list of drugs covered by insurance.
https://positivelyaware.com/prep-advocates-letter

Address

5537 N Broadway
Chicago, IL
60640

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(773) 989-9400

Website

Alerts

Be the first to know and let us send you an email when Positively Aware posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Positively Aware:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category